These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27313329)

  • 21. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
    Pérez-García A; De la Cámara R; Román-Gómez J; Jiménez-Velasco A; Encuentra M; Nieto JB; de la Rubia J; Urbano-Ispizúa A; Brunet S; Iriondo A; González M; Serrano D; Espigado I; Solano C; Ribera JM; Pujal JM; Hoyos M; Gallardo D;
    Blood; 2007 Jul; 110(1):461-7. PubMed ID: 17384200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
    Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
    Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
    Elbahlawan L; McArthur J; Quasney MW; Pei D; Srivastava K; Dahmer MK; Barfield R
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.
    Clark WB; Brown-Gentry KD; Crawford DC; Fan KH; Snavely J; Chen H; Savani BN; Kassim A; Greer JP; Schuening FG; Engelhardt BG; Jagasia MH
    Blood; 2011 Jul; 118(4):1140-4. PubMed ID: 21628416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant.
    Metafuni E; Giammarco S; Bellesi S; Rossi M; Minnella G; Limongiello MA; Valentini CG; Teofili L; Sica S; Chiusolo P
    Int J Lab Hematol; 2023 Dec; 45(6):935-944. PubMed ID: 37646104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
    Front Immunol; 2018; 9():109. PubMed ID: 29456530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.
    Lin MT; Storer B; Martin PJ; Tseng LH; Gooley T; Chen PJ; Hansen JA
    N Engl J Med; 2003 Dec; 349(23):2201-10. PubMed ID: 14657427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
    Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
    Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.
    Sato-Otsubo A; Nannya Y; Kashiwase K; Onizuka M; Azuma F; Akatsuka Y; Ogino Y; Satake M; Sanada M; Chiba S; Saji H; Inoko H; Kennedy GC; Yamamoto K; Morishima S; Morishima Y; Kodera Y; Sasazuki T; Ogawa S;
    Blood; 2015 Dec; 126(25):2752-63. PubMed ID: 26432889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
    Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
    Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.
    Carapito R; Jung N; Kwemou M; Untrau M; Michel S; Pichot A; Giacometti G; Macquin C; Ilias W; Morlon A; Kotova I; Apostolova P; Schmitt-Graeff A; Cesbron A; Gagne K; Oudshoorn M; van der Holt B; Labalette M; Spierings E; Picard C; Loiseau P; Tamouza R; Toubert A; Parissiadis A; Dubois V; Lafarge X; Maumy-Bertrand M; Bertrand F; Vago L; Ciceri F; Paillard C; Querol S; Sierra J; Fleischhauer K; Nagler A; Labopin M; Inoko H; von dem Borne PA; Kuball J; Ota M; Katsuyama Y; Michallet M; Lioure B; Peffault de Latour R; Blaise D; Cornelissen JJ; Yakoub-Agha I; Claas F; Moreau P; Milpied N; Charron D; Mohty M; Zeiser R; Socié G; Bahram S
    Blood; 2016 Oct; 128(15):1979-1986. PubMed ID: 27549307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
    Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
    Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation.
    Cho HJ; Shin DY; Kim JH; Bae JY; Lee KH; See CJ; Kim N; Park EK; Ra EK; Lee JE; Hong YC; Kim HK; Park SS; Yoon SS; Lee DS; Han KS; Park MH; Park S; Kim BK; Kim I
    Clin Transplant; 2012; 26(3):476-83. PubMed ID: 22035017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
    Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
    Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Socié G; Loiseau P; Tamouza R; Janin A; Busson M; Gluckman E; Charron D
    Transplantation; 2001 Aug; 72(4):699-706. PubMed ID: 11544434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
    La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor Killer Immunoglobulin-Like Receptor Haplotype B/x Induces Severe Acute Graft-versus-Host Disease in the Presence of Human Leukocyte Antigen Mismatch in T Cell-Replete Hematopoietic Cell Transplantation.
    Hosokai R; Masuko M; Shibasaki Y; Saitoh A; Furukawa T; Imai C
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):606-611. PubMed ID: 28042021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.
    Inamoto Y; Storer BE; Petersdorf EW; Nelson JL; Lee SJ; Carpenter PA; Sandmaier BM; Hansen JA; Martin PJ; Flowers ME
    Blood; 2013 Jun; 121(25):5098-103. PubMed ID: 23547053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.